The process of bringing a vaccine to market takes extensive research and safety monitoring. Dr. Gordon Douglas explains the steps from preclinical studies to vaccine licensure, and discusses his own experience developing vaccines at a major manufacturer for 30 years. He also shares lessons learned from clinical trials during the COVID-19 pandemic, including the importance of participant diversity.  

 Guest: R. Gordon Douglas, Jr, MD 

Host: Jo-Ana Chase, PhD, APRN-BC 

This podcast episode is supported by Seqirus. Content was developed by The Gerontological Society of America (GSA).